跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
首页
药物
A-PX
A-PX
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Recombinant bacterium for producing polymyxin B as well as construction method and application of recombinant bacterium
申请人: UNIV TIANJIN
优先权: 2024
CN
Cosmetic Composition Comprising Polymer Comprising Direct Crosslinks
申请人: FLOHR ANDREAS
优先权: 2011
US
Application of glucurolactone in preparation of medicine for treating or relieving neurotoxic diseases
申请人: UNIV HANGZHOU NORMAL
优先权: 2019
CN
Regulation of HIF protein levels via deubiquitination pathway
申请人: KIRKPATRICK LYNN
优先权: 2004
US
GOLD NANOCLUSTER IN THE TREATMENT OF FRIEDREICH'S ATAXIA
申请人: NOVYSTEM S P A
优先权: 2019
CN
EP
US
4 件公开
Application of PX-12 in preparation of coronavirus papaya-like protease PLPro inhibitor drug
申请人: DALIAN CHEMICAL PHYSICAL INST OF CHINESE ACADEMY OF SCIENCES
优先权: 2020
CN
Peptide extended glycosylated polypeptides
申请人: OKKELS JENS SIGURD
优先权: 2001
US
PEPTIDE EXTENDED GLYCOSYLATED POLYPEPTIDES
申请人: MAXYGEN APS
优先权: 2000
EP
WO
2 件公开
药物
反馈